Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Epidemiol Infect ; 147: e137, 2019 01.
Article in English | MEDLINE | ID: mdl-30869056

ABSTRACT

Carbapenem-resistant Enterobacteriaceae conferred by New Delhi metallo-b-lactamase (NDM-1) resistance mechanism are endemic in India and Southeast Asia. An understanding of risk factors for NDM-1 infections is necessary to guide prevention strategies. We performed a retrospective case-control study of patients admitted at Christian Medical College Hospital, Vellore, India between May 2010 and August 2014 with Klebsiella pneumoniae blood stream infection (BSI). We compared patients with BSI caused by NDM-1 producing strains to two control groups: BSI with other multidrug resistant (MDR) strains and BSI with pan-susceptible strains. The study groups were assessed for risk factors for the outcomes: (1) infection with any MDR strain compared to pan-susceptible; and, (2) infection with NDM-1 strain as compared with other MDR and (3) Mortality. A total of 101 patients with BSI with NDM-1 producing Klebsiella pneumoniae were matched to two groups of controls: 112 with non-NDM-1 MDR strains and 101 with pan-susceptible strains. Medical (OR 10.4) and neonatal (OR 0.7) ICU admission, central venous catheter placement (CVC, OR 7.4) predicted MDR BSI. Prior carbapenem use (OR 8.4) and CVC (OR 4.8) predicted acquisition of an NDM-1 strain. Significant predictors for mortality included ICU stay (OR 3.0), mechanical ventilation (OR 3.2), female gender (OR 2.2), diabetes (OR 0.4). CVC placement, prior carbapenem use and ICU admission were significantly associated with BSI with NDM-1 producing and other MDR strains.


Subject(s)
Bacteremia/epidemiology , Carbapenem-Resistant Enterobacteriaceae/isolation & purification , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/isolation & purification , beta-Lactamases/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Bacteremia/microbiology , Bacteremia/mortality , Carbapenem-Resistant Enterobacteriaceae/enzymology , Case-Control Studies , Child , Child, Preschool , Female , Humans , India/epidemiology , Infant , Infant, Newborn , Klebsiella Infections/microbiology , Klebsiella Infections/mortality , Klebsiella pneumoniae/enzymology , Male , Middle Aged , Retrospective Studies , Risk Factors , Survival Analysis , Young Adult
2.
Epidemiol Infect ; 141(6): 1328-36, 2013 Jun.
Article in English | MEDLINE | ID: mdl-22884022

ABSTRACT

Few studies have formally examined the relationship between meteorological factors and the incidence of child pneumonia in the tropics, despite the fact that most child pneumonia deaths occur there. We examined the association between four meteorological exposures (rainy days, sunshine, relative humidity, temperature) and the incidence of clinical pneumonia in young children in the Philippines using three time-series methods: correlation of seasonal patterns, distributed lag regression, and case-crossover. Lack of sunshine was most strongly associated with pneumonia in both lagged regression [overall relative risk over the following 60 days for a 1-h increase in sunshine per day was 0·67 (95% confidence interval (CI) 0·51-0·87)] and case-crossover analysis [odds ratio for a 1-h increase in mean daily sunshine 8-14 days earlier was 0·95 (95% CI 0·91-1·00)]. This association is well known in temperate settings but has not been noted previously in the tropics. Further research to assess causality is needed.


Subject(s)
Humidity , Pneumonia, Bacterial/etiology , Rain , Sunlight , Tropical Climate , Child, Preschool , Humans , Odds Ratio , Philippines/epidemiology , Pneumonia, Bacterial/epidemiology , Poisson Distribution , Regression Analysis , Risk Factors , Seasons
3.
S. Afr. j. infect. dis. (Online) ; 23(2): 17-19, 2008. tab
Article in English | AIM (Africa) | ID: biblio-1270587

ABSTRACT

The association of congenital heart disease with severe respiratory syncytial virus (RSV) lower respiratory tract infection is examined in this review. Current perspectives on prophylaxis for RSV in this patient subgroup are also discussed


Subject(s)
Heart Defects, Congenital , Respiratory Syncytial Virus Infections/physiopathology , Respiratory Syncytial Virus Infections/prevention & control , Review
4.
Trop Med Int Health ; 12(8): 962-71, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17697091

ABSTRACT

OBJECTIVE: To determine predictors of death among children 2-59 months old admitted to hospital with severe pneumonia. METHODS: Prospective observational study from April 1994 to May 2000 to investigate serious infections in children less than 5 years old admitted to a tertiary care government hospital in a rural province in central Philippines. The quality of clinical and laboratory work was monitored. The WHO classification for severe pneumonia was used for patient enrolment. RESULTS: There were 1249 children with severe pneumonia and no CNS infection. Thirty children died. Using univariate analysis, the following factors were significantly associated with death: age 2-5 months, dense infiltrates on chest radiography and presence of definite bacterial pathogens in the blood. Stepwise logistic regression analysis revealed the following independent predictors of death: age 2-5 months, weight for age z-score less than -2 SD, dense infiltrates on chest radiography and definite pathogens isolated in the blood. When the results of chest radiographs and blood cultures were not included to mimic facilities available at first-level facilities, age 2-5 months and weight for age z-score less than -2 SD remained independent predictors of death. CONCLUSION: When resources are limited, children with lower chest wall indrawing (severe pneumonia) who are 2-5 months old or moderately to severely malnourished should be referred for immediate higher-level care.


Subject(s)
Pneumonia/mortality , Analysis of Variance , Child, Preschool , Female , Hospital Mortality , Hospitalization , Humans , Infant , Male , Philippines/epidemiology , Pneumonia/diagnosis , Predictive Value of Tests , Prospective Studies , Risk Factors , Survival Rate
5.
Epidemiol Infect ; 135(7): 1077-90, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17346359

ABSTRACT

Our aim was to obtain knowledge of how meteorological conditions affect community epidemics of respiratory syncytial virus (RSV) infection. To this end we recorded year-round RSV activity in nine cities that differ markedly in geographic location and climate. We correlated local weather conditions with weekly or monthly RSV cases. We reviewed similar reports from other areas varying in climate. Weekly RSV activity was related to temperature in a bimodal fashion, with peaks of activity at temperatures above 24-30 degrees C and at 2-6 degrees C. RSV activity was also greatest at 45-65% relative humidity. RSV activity was inversely related to UVB radiance at three sites where this could be tested. At sites with persistently warm temperatures and high humidity, RSV activity was continuous throughout the year, peaking in summer and early autumn. In temperate climates, RSV activity was maximal during winter, correlating with lower temperatures. In areas where temperatures remained colder throughout the year, RSV activity again became nearly continuous. Community activity of RSV is substantial when both ambient temperatures and absolute humidity are very high, perhaps reflecting greater stability of RSV in aerosols. Transmission of RSV in cooler climates is inversely related to temperature possibly as a result of increased stability of the virus in secretions in the colder environment. UVB radiation may inactivate virus in the environment, or influence susceptibility to RSV by altering host resistance.


Subject(s)
Respiratory Syncytial Virus Infections/epidemiology , Respiratory Syncytial Viruses/growth & development , Weather , Disease Outbreaks , Humans , Humidity , Meteorological Concepts , Respiratory Syncytial Virus Infections/virology , Temperature , Ultraviolet Rays , United States/epidemiology
6.
J Perinatol ; 27(2): 112-9, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17262044

ABSTRACT

OBJECTIVE: To determine the bacterial etiology, clinical presentation and risk factors for outcome of serious community-acquired infections in young infants. STUDY DESIGN: Infants younger than 60 days, admitted for severe pneumonia or suspected sepsis/meningitis were prospectively evaluated using complete blood count, blood culture, chest radiograph, cerebrospinal fluid (CSF) culture in suspected meningitis. chi2 or Fisher's exact test and stepwise logistic regression were used for analysis. RESULTS: Thirty-four of 767 enrolled infants had a positive blood or CSF culture. Gram-negative bacteria were more frequent than Gram positive: overall (P=0.004), in those below 7 days of age (P=0.002) and among home deliveries (P=0.012). Case fatality rates were higher among infants below 1 week old (OR 4.14, P<0.001), those with dense (OR 2.92, P<0.001) or diffuse radiographic infiltrates (OR 2.79, P=0.003). CONCLUSIONS: Gram-negative enteric bacteria are the predominant causes of community-acquired infections in Filipino infants below 2 months old. Age below 7 days and radiographic pneumonia predicted death.


Subject(s)
Community-Acquired Infections/epidemiology , Gram-Negative Bacterial Infections/epidemiology , Age Distribution , Female , Humans , Infant, Newborn , Logistic Models , Male , Philippines/epidemiology , Risk Factors
7.
Pediatr Cardiol ; 26(1): 34-8, 2005.
Article in English | MEDLINE | ID: mdl-15793651

ABSTRACT

A retrospective chart review was conducted to examine risk factors associated with the occurrence of choreoathetosis, a rare but significant complication of open-heart surgery in children. Ten children were identified as having developed choreoathetosis after cardiac surgery. Their charts were reviewed and compared with 33 age- and diagnosis-matched controls who underwent open-heart surgery during the same time period. Children with choreoathetosis reached lower rectal and esophageal temperatures (p = 0.0018 for both) and spent a greater portion of total bypass time at lower rectal and esophageal temperatures (p < 0.001 for both). Duration of cooling below 20 degrees C esophageal temperature and PaCO2 at the end of the cooling period were significant predictors of choreoathetosis (p = 0.023 and p = 0.0497, respectively) in a logistic regression model, and a greater fraction of choreoathetosis patients had prior developmental delays (p = 0.017). No difference was found in the age at surgery, duration of bypass, aortic cross-clamp time, arterial pH, PaCO2 or mean arterial pressure. The combination of extended exposure to profound hypothermia and alpha-stat pH management strategy and preexisting developmental delay are associated with the development of choreoathetosis following open-heart surgery 61 in children.


Subject(s)
Athetosis/etiology , Cardiac Surgical Procedures , Chorea/etiology , Hypothermia, Induced/adverse effects , Acid-Base Equilibrium/physiology , Body Temperature , Carbon Dioxide , Cardiopulmonary Bypass , Esophagus/physiopathology , Humans , Hydrogen-Ion Concentration , Rectum/physiopathology , Retrospective Studies
9.
Respir Med ; 96 Suppl B: S1-7, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11996399

ABSTRACT

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in infants and young children worldwide, and an important cause of morbidity, hospitalization, and mortality. The infections caused by RSV are seasonal, peaking predictably in the winter months in temperate climates, and in the hottest months and the rainy season in tropical climates. The involvement of the lower respiratory tract, manifest clinically as bronchiolitis or pneumonia, is the hallmark of severe RSV disease. Other indicators of severe disease include requirement for, and duration of, hospitalization, supplemental oxygen, management in an intensive care setting, and mechanical ventilation. Host-related risk factors for severe RSV disease include preterm birth, infection before 6 months of age, chronic lung disease, and congenital heart disease. Environmental risk factors for severe RSV infection include poverty, crowding, exposure to tobacco smoke, and malnutrition. Factors that increase frequency of the infection include young age, multiple gestation, family history of atopy, lack of parental education, household crowding, older school-age siblings, lack of breast feeding, day-care attendance, passive smoke exposure, and discharge from a neonatal intensive care unit between September and December. Recent studies in Europe, North America and Japan have evaluated the number of children affected as well as the medical resources necessary to care for these children. Continuing surveillance is the key to tracking the seasonality, risk factors, morbidity and mortality associated with RSV infection. Epidemiological studies are also the basis for development of appropriate local prevention strategies.


Subject(s)
Developed Countries/statistics & numerical data , Infant, Premature, Diseases/epidemiology , Respiratory Syncytial Virus Infections/epidemiology , Respiratory Syncytial Virus, Human , Seasons , Canada/epidemiology , Europe/epidemiology , Humans , Incidence , Infant , Infant, Newborn , Infant, Premature , Japan/epidemiology , Risk Factors , United States/epidemiology
10.
Respir Med ; 96 Suppl B: S15-24, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11996400

ABSTRACT

Respiratory syncytial virus (RSV) is a common and highly contagious pathogen that infects nearly all children by the age of 2 years. It is responsible for significant morbidity and mortality worldwide among certain high-risk paediatric populations. Therapy is sub-optimal for RSV, thus treatment focuses on ameliorating symptoms. Since discovery of the virus in the 1950s, efforts have been ongoing to develop a safe and effective vaccine. These efforts have met with serious obstacles. Passive immunoprophylaxis presents a viable alternative to active immunization. In 1998, the genetically engineered humanized monoclonal antibody (palivizumab) was granted FDA (Food and Drug Administration) approval for prophylaxis of high-risk children in the United States; EMEA (European Agency for the Evaluation of Medicinal Products) approval followed in 1999 for Europe. It is now approved in over 45 countries worldwide. Palivizumab was shown to significantly reduce RSV-related hospitalizations in North America and Europe with few adverse effects. Clinical trial and outcomes data documenting experience with palivizumab to date continue to extend the initial safety and efficacy observations.


Subject(s)
Antibodies, Monoclonal/administration & dosage , Cross Infection/prevention & control , Infant, Premature, Diseases/prevention & control , Respiratory Syncytial Virus Infections/prevention & control , Respiratory Syncytial Virus, Human , Viral Vaccines/administration & dosage , Antibodies, Monoclonal, Humanized , Humans , Immunization, Passive , Infant , Infant, Newborn , Palivizumab , Respiratory Syncytial Virus, Human/immunology , Vaccines, Synthetic/administration & dosage , Viral Vaccines/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...